According to a survey of executives done by GlobalData Healthcare, the pharmaceutical industry’s top concern heading into 2023 is Inflation. The study, which was conducted between October 26 and November 23, found that CEOs ranked inflation as the biggest barrier to sector expansion, followed by restrictions on medicine prices and reimbursement, the crisis in the […]

The post Pharma Bosses See Inflation As The No. 1 Challenge In 2023 first appeared on World Pharma Today.